The United States has long been medtech’s largest and most complex market. For manufacturers and distributors considering entry to the U.S. market, true and comprehensive preparation is more important than ever. This involves extensive market analysis, a deep understanding of regulatory requirements, and other potentially difficult measures. So how can you set yourself up for success?
Part three of our series covers how to optimize distribution, sales, and marketing strategies in the U.S. ─ a notoriously difficult market for connecting these strategies to position your business for success.
Our speakers will share what it takes to prepare for U.S. operation and how to protect yourself against common pitfalls as you create your growth strategy.
Attendees will learn:
- How to access the right manufacturing and distribution networks
- How to evaluate potential partners
- How to adapt your business plan to the U.S. market
- How to chart effective sales strategies
- The relationship between marketing and sales in the U.S.
Watch Part 1 – Understanding the U.S. Medtech Market: Look Before You Leap
Watch Part 2 – Understanding U.S. Coding, Coverage and Reimbursement Models
Mark Lesselroth
President & CEO
BioPort USA
Mark is the President and CEO of BioPortUSA, commonly known as the gateway for life science companies into the United States. He has been instrumental in securing and building relationships for massive international companies like Siemens and start-ups developing breakthrough technologies for the U.S. healthcare market. Mark excels at bridging transatlantic relations that yield positive outcomes. Mark has been a featured presenter at BIO, MEDICA, Bionnale, bw-I, Medical Mountains, MedTech Bridge, WILCO, Bio-M, GACC NY, BIO Deutschland, and Upgraded Health. He is a peer reviewer for the Johns Hopkins Bloomberg School of Public Health, and is an active participant in several life science clusters both in the USA and Europe. When he is not traveling the world, he resides in Syracuse, NY with his wife and three children. In his free time, he enjoys tennis, golf, and good food.
Stéphan Toupin
President
Dawa Medical LLC
Over the last 27 years, Stéphan has gained a wealth of experience in the medtech and pharmaceutical industries with Astra Zeneca, Biovail and Novo Nordisk. Stéphan founded Dawa Medical in 2015 to collaborate with foreign medtech manufacturers to enter and succeed in the massive U.S. market. Dawa Medical is a United States Initial Importer and FDA agent with warehousing and distribution capabilities. Dawa Medical also offers services for the Canadian and Latin American markets.
